Evidence map›Paper›PMID 31317975›Full record

ArticleChemical communications (Cambridge, England)2019

Structure-activity-distribution relationship study of anti-cancer antimycin-type depsipeptides.

Jeremy Seidel, Yupeng Miao, William Porterfield, Wenlong Cai, Xuejun Zhu, Seong-Jong Kim, Fanghao Hu, Santi Bhattarai-Kline, Wei Min, Wenjun Zhang

Open access · greenAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Raman Spectroscopy for Chemical Biology Research.Journal of the American Chemical Society · 2022
    Review
  11. Article
  12. Miniaturized Chemical Tags for Optical Imaging.Angewandte Chemie (International ed. in English) · 2022
    Review
  13. Article
  14. Biosynthesis of Isonitrile- and Alkyne-Containing Natural Products.Annual review of chemical and biomolecular engineering · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jeremy SeidelDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA 94720, USA. wjzhang@berkeley.edu.
Yupeng Miao
William Porterfield
Wenlong Cai
Xuejun Zhu
Seong-Jong Kim
Fanghao Hu
Santi Bhattarai-Kline
Wei Min
Wenjun Zhang
Berkeley College · USColumbia University · US

Funding

Super-multiplex vibrational imaging in living cellsR01GM128214 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI MIN, WEI · 2018 to 2021
$1.5M
Optical imaging of small bio-molecules in living cells and tissues by nonlinear Raman microscopy coupled with vibrational tagsR01EB020892 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI MIN, WEI · 2015 to 2018
$1.3M
NIBIB NIH HHS R01 EB020892NIGMS NIH HHS R01 GM128214
6 · The paper itself

Abstract

Small-molecule natural products have been an essential source of pharmaceuticals to treat human diseases, but very little is known about their behavior inside dynamic, live human cells. Here, we demonstrate the first structure-activity-distribution relationship (SADR) study of complex natural products, the anti-cancer antimycin-type depsipeptides, using the emerging bioorthogonal Stimulated Raman Scattering (SRS) Microscopy. Our results show that the intracellular enrichment and distribution of these compounds are driven by their potency and specific protein targets, as well as the lipophilic nature of compounds.

Indexed as

Antimycin AAntineoplastic AgentsCell SurvivalDepsipeptidesHeLa CellsHumansMCF-7 CellsMicroscopy, FluorescenceSpectrum Analysis, RamanStructure-Activity RelationshipantimycinAntimycin AAntineoplastic AgentsDepsipeptides

Identifiers

PMID31317975
PMCPMC6675640
OpenAlexW2957932170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.